- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT06436014
Evaluation of the Effect of Virtual Reality Application on Postoperative Pain and Anxiety in Women (Pain)
Effects of a Nature-Based Virtual Reality Intervention on Postoperative Pain and Anxiety in Women Undergoing Total Knee Arthroplasty or Cesarean Delivery: A Randomized Controlled Study
Surgical interventions, while significant milestones in patients' physical recovery processes, can be a major source of concern for patients due to postoperative pain, which is also an important component of postoperative care. If postoperative pain is not managed properly, it can lead to increased levels of anxiety and fear, as well as deterioration in overall comfort and quality of life. The ineffective management of postoperative pain has economic and medical consequences such as patient dissatisfaction, delayed hospital discharge, increased rates of hospital readmission, and dissatisfaction with medical care. Therefore, effective management of postoperative pain is of great importance for patient well-being. Factors associated with postoperative pain have been reported in many studies. For example, being female and the type of surgery. Therefore, considering gender and type of surgery in the management of postoperative pain is crucial to optimize the recovery process for patients. In recent years, research on the use of innovative technologies such as virtual reality in the management of postoperative pain has increased. Virtual reality can reduce postoperative pain by creating a sense of being in a different environment for patients and diverting their attention away from pain.
Przegląd badań
Status
Warunki
Interwencja / Leczenie
Szczegółowy opis
This randomized controlled trial evaluated the effects of virtual reality (VR) on postoperative pain, anxiety, physiological parameters, and analgesic use in women aged 18 years and older undergoing total knee arthroplasty (TKA) or cesarean section (CS) at Osmaniye State Hospital. The study also examined whether the effects of VR differed by surgery type.
Within each surgery category, eligible participants were assigned to VR or control groups using a lottery method performed by clinical nurses who were not members of the research team. Folded slips indicating VR or control allocation were drawn from a box, resulting in four groups: VR-TKA, control-TKA, VR-CS, and control-CS. Participants, the intervention provider, and the outcome assessor were aware of group allocation.
Baseline assessments (T1) were performed at postoperative hour 24, 40 minutes after analgesic administration. Pain and anxiety were assessed using separate 10-cm Visual Analog Scales (VAS). Physiological measurements included systolic and diastolic blood pressure, pulse rate, and peripheral oxygen saturation (SpO₂).
Participants in the VR groups received a 10-minute VR session in addition to routine postoperative care. They selected one of four relaxing nature videos featuring lake and river scenery, the sea and a tropical beach, morning nature scenes, or forest scenery. The device and planned intervention duration were standardized, while content selection reflected individual preferences. Videos were presented without headphones at the device's maximum volume. Control groups received routine postoperative care without VR. All assessments were repeated immediately after the 10-minute intervention or corresponding control period (T2). VR sessions and assessments were conducted with participants in a semi-sitting position in bed.
Analgesic use was obtained from patient records and medication administration charts. Video preferences, intervention completion, and participants' feedback regarding their VR experience were recorded. When participants reported dizziness, the video was stopped. Sixteen participants discontinued VR because of dizziness; the final analyses included 126 participants who completed the study: 36 in VR-TKA and 30 in each of the other three groups.Analgesic use was obtained from patient records and medication administration charts. Video preferences, intervention completion, participants' feedback regarding their VR experience, and the occurrence of dizziness during the VR session were recorded. When participants reported dizziness, the video was stopped, and their T2 assessments were performed at the time the headset was removed. Sixteen participants discontinued VR because of dizziness.
The primary analysis included all 142 randomized participants in the groups to which they were assigned (intention-to-treat), using analysis of covariance (ANCOVA) with the T2 score as the dependent variable, the T1 score as the covariate, and VR status and surgery type as fixed factors, including their interaction. Two sensitivity analyses were performed: a conservative analysis in which the T1 scores of participants who discontinued VR were carried forward as their T2 scores (n = 142), and a per-protocol analysis including only participants who completed the intervention (n = 126: 36 in VR-TKA and 30 in each of the other three groups). The primary models were also repeated with age as an additional covariate.
The study was initially approved by the Osmaniye Korkut Ata University Ethics Committee on November 29, 2023 (Decision No. 2023/8/3), and institutional permission was obtained from Osmaniye State Hospital on December 22, 2023. However, after the gynecologic surgeons left the hospital, hysterectomy procedures were no longer performed, and eligible hysterectomy patients could not be recruited. Therefore, the hysterectomy group was replaced with a cesarean section group, and a protocol amendment was approved by the ethics committee on March 2, 2026 (Decision No. 2026/3/2). Recruitment of cesarean section participants began after this amendment was approved.Data for the total knee arthroplasty groups were collected between January 2024 and December 2024 under the initial ethics approval. Data for the cesarean section groups were collected between March 2026 and November 2026, after the protocol amendment had been approved. Ethical approval was obtained from the Osmaniye Korkut Ata University Ethics Committee (Decision No. 2023/8/3, November 29, 2023), and institutional permission was obtained from Osmaniye State Hospital (December 22, 2023). A protocol amendment replacing the hysterectomy group with a cesarean section group was approved on March 2, 2026 (Decision No. 2026/3/2). Written informed consent was obtained from all participants, and the study was conducted in accordance with the Declaration of Helsinki.
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Lokalizacje studiów
-
-
Osmani̇ye
-
Center, Osmani̇ye, Turcja (Türkiye), 80010
- Osmaniye Korkut Ata University
-
Center, Osmani̇ye, Turcja (Türkiye), 80010
- Osmaniye State Hospital
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
- Being female and aged 18 years or older.
- Having undergone total knee arthroplasty or cesarean section.
- Being at postoperative hour 24.
- Being conscious and able to communicate.
- Being able to understand the assessment instruments.
- Having no severe visual or hearing impairment or physical condition that would prevent the use of a VR headset.
Exclusion Criteria:
- Having severe cognitive or communication difficulties.
- Experiencing deterioration in clinical condition.
- Having a neurological or vestibular disorder.
- Experiencing active nausea or vomiting.
- Having an active eye infection.
- Having wounds in the facial or head region that would interfere with VR headset use.
Withdrawal Criterion:
- Requesting withdrawal from the study.
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie podtrzymujące
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Podwójnie
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
|---|---|
|
Eksperymentalny: Total Knee Replacement VR Intervention Group
Participants who underwent total knee arthroplasty completed baseline assessments (T1) of pain and anxiety using separate 10-cm Visual Analog Scales (VAS), along with measurements of systolic and diastolic blood pressure, pulse rate, and SpO₂. They then received a 10-minute VR intervention in addition to routine postoperative care. All assessments were repeated immediately after the intervention (T2). |
Participants undergoing VR intervention will experience a VR program of their choice based on personal preferences. Among these programs are videos offering natural visual experiences. For instance, participants can opt for videos featuring seaside views, forest tours, or lake landscapes. |
|
Brak interwencji: Total Knee Replacement Control Group
Participants who underwent total knee arthroplasty completed baseline assessments (T1) of pain and anxiety using separate 10-cm Visual Analog Scales (VAS), along with measurements of systolic and diastolic blood pressure, pulse rate, and SpO₂. They received routine postoperative care without VR. All assessments were repeated after the same 10-minute interval used in the VR group (T2). |
|
|
Eksperymentalny: Cesarean Section VR Intervention Group
Pre-Test + Intervention + Post-Test) Participants who underwent cesarean section surgery and received a pre-test, followed by VR intervention.Participants in this group are initially assessed with a pre-test, followed by VR intervention. |
Participants undergoing VR intervention will experience a VR program of their choice based on personal preferences. Among these programs are videos offering natural visual experiences. For instance, participants can opt for videos featuring seaside views, forest tours, or lake landscapes. |
|
Brak interwencji: Total Knee Group
Participants who underwent total knee arthroplasty completed baseline assessments (T1) of pain and anxiety using separate 10-cm Visual Analog Scales (VAS), along with measurements of systolic and diastolic blood pressure, pulse rate, and SpO₂. They received routine postoperative care without VR. All assessments were repeated after the same 10-minute interval used in the VR group (T2). |
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
The VR application is effective in changing postoperative pain.
Ramy czasowe: The researcher's first visit to the patient on postoperative day 1.
|
Pain intensity was assessed using a 10-cm Visual Analog Scale (VAS) in women aged 18 years and older undergoing total knee arthroplasty or cesarean section. Baseline assessments (T1) were performed at postoperative hour 24, 40 minutes after analgesic administration. Participants in the VR groups then received a 10-minute VR intervention alongside routine care, while control groups continued to receive routine care alone. Pain intensity was reassessed (T2) immediately after this 10-minute period in all groups. |
The researcher's first visit to the patient on postoperative day 1.
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
The VR application is effective in changing postoperative anxiety.
Ramy czasowe: The researcher's first visit to the patient on postoperative day 1.
|
Pain intensity was assessed using a 10-cm Visual Analog Scale (VAS) in women aged 18 years and older undergoing total knee arthroplasty or cesarean section. Baseline assessments (T1) were performed at postoperative hour 24, 40 minutes after analgesic administration. Participants in the VR groups then received a 10-minute VR intervention alongside routine care, while control groups continued to receive routine care alone. Pain intensity was reassessed (T2) immediately after this 10-minute period in all groups. |
The researcher's first visit to the patient on postoperative day 1.
|
Współpracownicy i badacze
Sponsor
Śledczy
- Główny śledczy: Songül GÜNGÖR, Phd, Osmaniye Korkut Ata University
- Dyrektor Studium: Ayşe TAŞTEKİN, associate professor, Afyonkarahisar Health Sciences University
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- OsmaniyeKorkutAtaUniversity
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .